Regor Therapeutics Group vs Septerna
Regor Therapeutics Group
We aspire to be a world class innovative drug discovery company from China
35 employees · est. 2018 · Shanghai, China
Septerna
Bringing a new era of GPCR medicines to patients with its Native Complex Platform™
137 employees · est. 2022 · South San Francisco, United...
Regor Therapeutics Group is the older company (2018 vs 2022); Septerna is the larger of the two.
Side-by-Side Comparison
| Metric | Regor Therapeutics Group | Septerna |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2022 |
| Headquarters | ||
| Headquarters | Shanghai, China | South San Francisco, United States |
| Employees | ||
| Employees | 35 | 137 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | IPO |
| Total Funding | ||
| Total Funding | $140.00M | $552.60M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Drug discovery and development, Preclinical candidate optimization, Clinical trials and studies, Partnerships with pharmaceutical companies, Licensing of drug candidates | Discovery of GPCR-targeted drug candidates, Development of oral small molecule therapies, Optimization of GPCR drug targets |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Healthcare providers, Oncologists, Researchers in metabolic and immunological diseases | Patients with unmet medical needs, Healthcare providers, Medical researchers, Pharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Drug DiscoveryClinical-Stage CompanyInnovative MedicinesOncologyImmunologyMetabolic Disorders +9 | GPCR MedicinesNative Complex PlatformSmall-molecule DrugsDrug DiscoveryBiochemical AdvancesStructural Drug Development +8 |
| Website | ||
| Website | regor.com | septerna.com |
About Regor Therapeutics Group
Regor Therapeutics Group, founded in 2018 and based in China, aims to position itself as a leader in innovative drug discovery. With a focus on oncology, immunology, and metabolic disorders, the company leverages its proprietary CARD (Computer Accelerated Rational Discovery) Platform to develop clin...
About Septerna
Septerna, founded in 2022, is a biotechnology and pharmaceutical company headquartered in the United States. With the slogan, "Bringing a new era of GPCR medicines to patients with its Native Complex Platform™," the company is pioneering innovations in the GPCR landscape. Septerna aims to transform...
Also comparing in this category
Comparing more than these two?
Get Regor Therapeutics Group, Septerna and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Regor Therapeutics Group compare?
A PDF of Regor Therapeutics Group and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Regor Therapeutics Group with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Regor Therapeutics Group on 15 Jun 2026, and Septerna on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
